That is the problem with a lot of investors. Look at Juno and its Phase II results. Our situation is something much different and very new in its structure. The FDA is mandating a reduction in nicotine content of cigarettes. We do not have to guess much knowing the die has been cast
...and therein lies the problem for investors...investors dreaming and cheer leading rather then challenging alleged "facts" out of XXII, which don't add up with other alleged "facts" from BT. IMO...BT statements don't align with XXII's "facts" (i.e. only company with or who can develop the VLN technology).
Then on top of that you have the "time factor". Timing of VLN mandate very uncertain.
I remain flat unless and until there is clarity and resolution of those more fundamental "facts".
News 
Market Data 
Discover 
